Gynecology/Obstetrics News

Researchers developed a prediction tool that may help to limit the number of surplus embryos created with IVF while maintaining the likelihood of live birth.

The FDA finalized changes to its dispensing requirements for mifepristone to allow certified pharmacies to provide the abortifacient to patients, according to updated postmarket drug safety information.

Restrictions on reproductive care access were associated with higher state-level rates of suicide among reproductive-aged women, according to a study published in JAMA Psychiatry.

Among Healio Women’s Health & OB/GYN content, abortion-related articles were some of the most read content this year.

COVID-19 vaccination, regardless of type, was not associated with lower odds of pregnancy by artificial insemination by partner among couples in China, according to data published in JAMA Network Open.

Foot massages were found to decrease sleep disturbances, fatigue and anxiety symptoms during menopause, according to a study published in Menopause earlier this year.

Availability of telehealth significantly reduced disparities in postpartum visit attendance between Black and non-Black patients, researchers reported in the American Journal of Obstetrics & Gynecology Maternal-Fetal Medicine.

Among the top content with the hashtag #IUD on TikTok, more videos were negative about IUDs than positive, and more than one in four discussed distrust of medical professionals, according to data published in Obstetrics & Gynecology.

Pregnancy termination through medication abortion without prior pelvic exam or ultrasonogram is safe and effective, according to findings of a systematic review published in Obstetrics & Gynecology.

The FDA “appears poised” to withdraw the only drug indicated for the prevention of preterm birth from the market following a recent recommendation to do so.